The only consolation, not that it's much of one, is that volume has been low. Most are holding, small individual SHs that are fed up are selling, and not too many of them either. At this point, doesn't seem to be much use in selling.
But you are correct, this is BK pricing for a company with a huge list of valuable patents in an extremely difficult field of science to break into, zero, 0, none, zilch debt and $22M in the bank. Management made a pivot to agriculture for human and animal consumption very late in the game, and only when they had little choice given the snail's pace progress they are making in biomass down in Brazil. What irks me most is the lack of any kind of reaction by the BOD to what is clearly failed management.
Market is essentially saying there is absolutely no hope, that management will simply continue spending and raising money until they are forced to fold. Perhaps that's what they want. If they simply fold and pack up rather tan having to declare BK, the patents remain under the names of the inventors, not the company, I think. In other words. they get to start all over again with the value of the patents intact. SHs get nothing for having financed their science experiment to the tune of approx $300M since IPO.
These posts are becoming ubiquitous, sort of like the legal loan sharking shops popping up everywhere. Signs of serious trouble brewing, IMO.
Good idea. Call or write and if you don't get a response, do it again. Ask that your message be passed on to the BOD as well, because it is they who are supposed to be looking after SH interests. At some point, they have to at least acknowledge their predicament rather than behave like everything is going swimmingly. Strategic alternatives, it's time.
What? You are clueless.
Not sure about the company, but the stock is poised for a comeback. It's liquid, it's technology is relevant if not immediately marketable, and this is the way WS Juniors makes money. Run up dead stocks, sell and walk away. See IMRS, BGMD. Same thing happening. IMRS might be actually recovering though, they do have fascinating tech.
They need the money to fund operations. Looks like a lot but they burn through $6M/Q, so it's less than a year's worth of funding. That oft-touted Brazilian grant money better come in soon.
Let me know when the sky starts falling cause I've been watching since last night and it seems pretty stable to me. In an added measure of irony, the DAX is way up today.
In so far as you insult or ridicule Europe or Greece, consider that US debt to GDP is just a tad better than Italy's. The US can seemingly print ad nauseum due to the $'s status and a huge conventional and nuclear arsenal. That's the only thing keeping the US from becoming Greece, minus the culture, great food, beautiful women and incredible history.
Believe it when I see it. Maybe the CEO will spend another $2K on a market buy! That would put CEREs in the black for sure.
Orwell quote is correct, context however is a lie. Same old lying SoS, ain't ya now?
As much as anyone here I'm afraid. Maybe the grand insider buys will make the difference? You know, the ones you point out without mentioning their immense value of a few hundred $? At this price point, the CEO can buy 1000 shares with about an hrs worth of his annual compensation.
Now that's a good idea. Already being done anyway, might as well do it right. They've been at this for years, in the hopes of a few scraps in the form of grants and loans. Investors have given up hope that the value of the scene and patent portfolio will ever be realized by CEREs Inc. Either sell it or jump into a side business that will help sustain while the research and field trials #$%$ for God knows how much longer before monetization.
The last 4 filings in the last 2 days total insider purchases of 8000 shares, approx $1700.00. Just keeping it real. Better than nothing, but not by much. Could be guilt purchases, lol. Anyway, today was mildly encouraging.
No, do some homework. A new secondary, at say $0.10, would pretty much dilute them and all existing shareholders into insignificance, but a RS is just that, it is not dilution.
No idea, perhaps a RS, perhaps OTC is better for a company like this anyway. In any event, looks like it'll break .20 today for the first time.
I dunno, this small company has a $1/2M CEO. Throwing $22K at insider purchase for 100K shares wouldn't have been much of a burden. But less than $500? It's almost insulting. These are all-time lows, it doesn't get better (or worse) than this. Well, I guess it could.
Sorry, Nas site shows it, but not SEC site? Anyway, 2000 shares is hardly worthy of a filing. Less that $500. Not exactly a big gamble.